Literature DB >> 32860071

Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Shveta V Parekh1, Jacqueline E Paniccia1, Christina L Lebonville1, Donald T Lysle2.   

Abstract

Converging evidence suggests opioid abuse can increase the incidence and severity of post-traumatic stress disorder (PTSD) in clinical populations. Interestingly, opioid withdrawal alone can produce symptoms similar to those of PTSD. Despite this association, the neural mechanisms underlying the relationship of opioid abuse, withdrawal, and PTSD is poorly understood. Our laboratory has investigated the neurobiological underpinnings of stress-enhanced fear learning (SEFL), an animal model of PTSD-like symptoms. We have previously shown that, in SEFL, a severe footshock induces an increase in dorsal hippocampal (DH) interleukin-1β (IL-1β), and subsequent fear learning is blocked by DH IL-1 receptor antagonism (IL-1RA). Given that opioids and stress engage similar neuroimmune mechanisms, the present experiments investigate whether the same mechanisms drive heroin withdrawal to induce a PTSD-like phenotype. First, we tested the effect of a chronic escalating heroin dose and withdrawal regimen on fear learning and found it produces enhanced future fear learning. Heroin withdrawal also induces a time-dependent, region-specific increase in IL-1β and glial fibrillary acidic protein (GFAP) immunoreactivity within the dentate gyrus of the DH. IL-1β was significantly colocalized with GFAP, indicating astrocytes may be involved in increased IL-1β. Moreover, intra-DH infusions of IL-1RA 0, 24, and 48 h into heroin withdrawal prevents the development of enhanced fear learning but does not alter withdrawal-induced weight loss. Collectively, our data suggests heroin withdrawal is sufficient to produce enhanced fear learning, astrocytes may play a role in heroin withdrawal-induced IL-1β, and DH IL-1 signaling during withdrawal mediates the development of heroin withdrawal-enhanced fear learning.

Entities:  

Keywords:  Glia; Heroin; Neuroimmunology; Opioid; PTSD; Withdrawal

Mesh:

Substances:

Year:  2020        PMID: 32860071      PMCID: PMC7686097          DOI: 10.1007/s00213-020-05645-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  49 in total

1.  Cytokine levels as potential biomarkers for predicting the development of posttraumatic stress symptoms in casualties of accidents.

Authors:  Miri Cohen; Tamar Meir; Ehud Klein; Gershon Volpin; Michael Assaf; Shimon Pollack
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

2.  Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Daniel J Urban; Xiaohui Wang; Michael V Baratta; Timothy J Fabisiak; Nathan D Anderson; Kejun Cheng; Lisa I Greene; Debra Berkelhammer; Yingning Zhang; Amanda L Ellis; Hang Hubert Yin; Serge Campeau; Kenner C Rice; Bryan L Roth; Steven F Maier; Linda R Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

3.  Opioid-Involved Overdose Among Male Afghanistan/Iraq-Era U.S. Military Veterans: A Multidimensional Perspective.

Authors:  Alex S Bennett; Luther Elliott; Andrew Golub; Brett Wolfson-Stofko; Honoria Guarino
Journal:  Subst Use Misuse       Date:  2017-06-16       Impact factor: 2.164

4.  Implementing prescription drug monitoring and other clinical decision support for opioid risk mitigation in a military health care setting: a qualitative feasibility study.

Authors:  Erin P Finley; Suyen Schneegans; Claudina Tami; Mary Jo Pugh; Don McGeary; Lauren Penney; Jennifer Sharpe Potter
Journal:  J Am Med Inform Assoc       Date:  2018-05-01       Impact factor: 4.497

5.  Ballistic labeling and dynamic imaging of astrocytes in organotypic hippocampal slice cultures.

Authors:  Adrienne M Benediktsson; Scott J Schachtele; Steven H Green; Michael E Dailey
Journal:  J Neurosci Methods       Date:  2005-01-30       Impact factor: 2.390

6.  High-Resolution Three-Dimensional Imaging of Individual Astrocytes Using Confocal Microscopy.

Authors:  Anze Testen; Ronald Kim; Kathryn J Reissner
Journal:  Curr Protoc Neurosci       Date:  2020-03

7.  Suppression of hypothalamic-pituitary-adrenal axis by acute heroin challenge in rats during acute and chronic withdrawal from chronic heroin administration.

Authors:  Yan Zhou; Francesco Leri; Ann Ho; Mary Jeanne Kreek
Journal:  Neurochem Res       Date:  2013-06-16       Impact factor: 3.996

8.  Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions.

Authors:  V F Gellert; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

9.  Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse.

Authors:  J D Bremner; S M Southwick; A Darnell; D S Charney
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

10.  Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal.

Authors:  Jennifer Kaufling; Gary Aston-Jones
Journal:  J Neurosci       Date:  2015-07-15       Impact factor: 6.167

View more
  4 in total

1.  Hippocampal TNF-α Signaling Mediates Heroin Withdrawal-Enhanced Fear Learning and Withdrawal-Induced Weight Loss.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Lydia O Adams; Donald T Lysle
Journal:  Mol Neurobiol       Date:  2021-02-13       Impact factor: 5.590

Review 2.  Rapidly Growing Mycobacterium Species: The Long and Winding Road from Tuberculosis Vaccines to Potent Stress-Resilience Agents.

Authors:  Mattia Amoroso; Dominik Langgartner; Christopher A Lowry; Stefan O Reber
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

Review 3.  Astrocytes in Post-traumatic Stress Disorder.

Authors:  Baoman Li; Dianjun Zhang; Alexei Verkhratsky
Journal:  Neurosci Bull       Date:  2022-03-29       Impact factor: 5.271

4.  Linagliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor, Reduces Physical and Behavioral Effects of Morphine Withdrawal.

Authors:  Joanna Listos; Piotr Listos; Irena Baranowska-Bosiacka; Agata Karpiuk; Joanna Filarowska; Małgorzata Łupina; Tymoteusz Słowik; Sylwia Zawiślak; Jolanta Kotlińska
Journal:  Molecules       Date:  2022-04-12       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.